Home

P. Global Health, Travel Medicine and Parasitology

 

Meet-the-Experts

 

Controversies in Pre-Travel Preparation

Developed in cooperation with the American Society of Tropical Medicine & Hygiene (ASTMH)

Cases will illustrate new advances and emerging issues and challenges in travel medicine.

Upon completion of this Meet-the-Expert Session, the participant should be able to:

• Cite some of the latest significant literature on travel medicine; and
• Discuss the epidemiology of travel related illnesses and issues in prevention of these illnesses. 

Expert:
Michael D. Libman, MD; McGill Univ., Montreal, Canada.

 

Top Ten Papers in Travel and Tropical Medicine

Developed in cooperation with the American Society of Tropical Medicine & Hygiene (ASTMH)

Presentation and discussion of top ten papers in travel and tropical medicine in the last year. Papers are chosen to illustrate new advances and emerging issues and challenges in travel and tropical medicine and global health.

Upon completion of this Meet-the-Experts Session, the participant should be able to:

• Cite the latest significant literature on travel medicine; and
• Describe the epidemiology of travel related illnesses and will understand issues in prevention of these illnesses. 

Expert:
Eric Caumes, MD; Hosp. Pitié-Salpêtrière, Univ. Pierre-et-Marie-Curie, Paris, France.

 

Symposia

 

Global Health as an Academic Discipline

Developed in cooperation with the American Society of Tropical Medicine & Hygiene (ASTMH)

Symposium designed to inform and update trainees and those early in their careers, about opportunities for pursuing an academic career in global health. A range of MDs and PhDs currently active in global health will detail both their personal experience as well as review new prospects for those wishing to pursue career development in the field of global health.

Upon completion of this Symposium Session, the participant should be able to:

• Assess the opportunities for pursuing an academic career in global health; and
• Access websites and literature relevant to academic training and professional career development in global health. 

Conveners:
Kevin Kain, MD; Univ. of Toronto, Toronto, Canada.
Alan J. Magill, MD; Defense Sci. Office (DSO), Defense Advanced Res. Programs Agency (DARPA), Washington, DC.

Presentations:
Academic Institutions and Career Development in Global Health
Michele Barry, MD; Stanford Univ. Sch. of Med., Palo Alto, CA.

CDC and Public Health Careers in Global Health
Martin Cetron, MD; CDC, Atlanta, GA.

Uniformed Services Career Paths in Global Health
Phil Coyne Jr., MD, MSPH; Uniformed Services Univ. of Hlth. Sci., Bethesda, MD.

Foundations and Opportunities in Global Health
Regina Rabinovitch, MD, MPH; Bill and Melinda Gates Fndn., Seattle, WA.

European Perspective on Global Health Training and Career Paths
Frank Von Sonnenburg, MD; Univ. of Munich, Munich, Germany.

 

Update on Drug Resistance in Malaria

This symposium is designed to update the attendees on the current global status of drug resistance in Malaria worldwide. The session will address current epidemiology of molecular markers and confirmed therapeutic failures, the status of biomarker and molecular marker search for artemisninin resistance marker, and the current global efforts to contain resistance in Southeast Asia.

Upon completion of this Symposium Session, the participant should be able to:

• Describe the current global distribution of genotypic and phenotypic markers associated with drug resistance to malaria;
• Compare the difference between therapeutic failures and drug resistance;
• Recognize the technical and biologic difficulties in isolating and identifying the genetic correlates of acquired drug resistance in malaria; and
• Interpret genotypic and phenotypic data acquired in the laboratory and apply to treatment recommendations.

Conveners:
Thomas Wellems, MD, PhD; NIAID, NIH, Bethesda, MD.
Alan Magill, MD; Defense Sci. Office, Defense Advanced Res. Programs Agency, Arlington, VA.

Presentations:
What Can We Learn from the History of Emerging Drug Resistance to Anti-Malarial Drugs?
Thomas E. Wellems, MD, PhD; NIAID, NIH, Bethesda, MD.

Emerging Artemisinin Resistance in Plasmodium falciparum Malaria
Rick M. Fairhurst, MD, PhD; NIAID, NIH, Bethesda, MD.

Chloroquine Resistant Plasmodium vivax Malaria
Kevin Baird, PhD; Eijkman-Oxford Clinical Res. Unit, Jakarta, Indonesia.

Malaria Drug Discovery and Development for the Coming Decade
Tim Wells, PhD; Med. for Malaria Venture, Geneva, Switzerland.

 

Best Practices for Serologic Testing in Selected Parasitic Diseases

Parasitologic confirmation, usually by visualization of a parasite life form in biologic specimens, is the preferred diagnostic approach for the diagnosis of parasitic diseases. For some infections a parasitological diagnosis is not feasible or has very low sensitivity. For example in neurocysticercosis, where the tapeworm cysts are found in the brain, parasitological confirmation is not possible and for other infections such as strongyloidiasis, larval shedding in the stool is infrequent and in low numbers making stool exams rather insensitive. In these settings serologic testing is essential and sometimes the only available test to confirm the diagnosis and guide management of selected parasitic diseases. In this symposium we will look closely at three common and problematic parasitic infections: neurocysticercosis, schistosomiasis, and stonglyloidiasis. Experts in the clinical management of these diseases will explain the currently available serologic tests for common clinical settings. Finally, the role of serologic testing in a reference laboratory will be reviewed.

Upon completion of this Symposium Session, the participant should be able to:

• Update the clinical community on the appropriate use of currently available serologic testing for the diagnosis of three major infectious diseases using a case-based interactive format;
• Discuss the advantages and limitations of serologic testing in the diagnosis and management of neurocysticercosis, schistosomiasis, and strongyloidiasis; and 
• Describe the reference capabilities for the CDC DPDM to support clinicians. 

Conveners:
Alan J. Magill, MD, PhD; Defense Advanced Res. Projects Agency (DARPA), Arlington, VA.
Patricia Wilkins, PhD; CDC, Atlanta, GA.

Presentations:
The Serologic Diagnosis of Neurocysticercosis
Hector Garcia, MD, PhD; Univ. Peruana Cayetano Heredia, Lima, Peru.

The Serologic Diagnosis of Schistosomiasis
Thomas Nutman, MD; NIAID, NIH, Bethesda, MD.

The Serologic Diagnosis of Strongyloidiasis
Jay S. Keystone, MD, MSc (CTM), FRCPC; Toronto Gen. Hosp., Toronto, Canada.

The CDC Reference Lab and Serologic Diagnosis
Patricia Wilkins, PhD; CDC, Atlanta, GA.

 

 

Interactive Symposia

 

Clinical Problem Solving: Interactive Cases in Travel and Tropical Medicine

Developed in cooperation with the American Society of Tropical Medicine & Hygiene (ASTMH)

Case-based, audience interactive format to teach travel and tropical medicine. Cases are chosen to illustrate common clinical problems and emerging issues that arise in these fields.

Upon completion of this Interactive Symposium Session, the participant should be able to: 

• Cite some of the latest significant literature of travelers’ medicine, parasitology, and tropical medicine; and 
• Discuss the epidemiology of travelers’ illnesses and will understand issues in management and prevention of these illnesses. 

Conveners:
Kevin Kain, MD; Univ. of Toronto, Toronto, Canada.
Alan J. Magill, MD; Defense Sci. Office, Defense Advanced Res. Programs Agency, Washington, DC.

Presentations:
Blood-Borne Pathogen Exposures During Travel
Michael Gardam, MD; Univ. Hlth. Network, Toronto Gen. Hosp., Toronto, Canada.

Managing Animal Bites in Travelers
David Shlim, MD; Jackson Hole Travel and Tropical Med., Jackson, WY.

Tropical Dermatology
Scott A. Norton, MD; Georgetown Univ. Hosp., Washington, DC.

Immigrants and VFRs
Rogelio López-Vélez, MD, DTM&H, PhD; Ramón y Cajal Hosp., Madrid, Spain.

 

What’s Hot Where it's Hot: Interactive Cases in Tropical Medicine

Developed in cooperation with the American Society of Tropical Medicine & Hygiene (ASTMH)

Case-based, audience interactive format to teach travel, tropical, and parasitology medicine. Cases are chosen to illustrate new and emerging issues in these fields.

Upon completion of this Interactive Symposium Session, the participant should be able to:

• Cite some of the latest significant literature of travelers medicine, parasitology, and tropical medicine; and
• Discuss the epidemiology of travelers’ illnesses and issues in management and prevention of these illnesses. 

Convener:
Wesley C. Van Voorhis, MD, PhD; Univ. of Washington, Seattle, WA.

Panelists: 
Stephen D. Shafran, MD; Univ. of Alberta, Edmonton, Canada.
Eric Caumes, MD; Hosp. Pitié-Salpêtrière, Univ. Pierre-et-Marie-Curie, Paris, France.
Michael D. Libman, MD; McGill Univ. Hlth. Ctr., Montreal, Canada.
David R. Hill, MD; UCLH NHS Fndn. Trust, London, United Kingdom.
Christina M. Coyle, MD; Jacobi Hosp., Larchmont, NY.